OCT 23, 2026 · JOURNAL ARTICLE
Hypoxemia and pulmonary infiltrates during T-cell-engaging bispecific antibody therapy: A pulmonary and critical care framework
Respiratory Investigation
T-cell-engaging bispecific antibodies (BsAbs) have rapidly expanded treatment options for relapsed or refractory multiple myeloma, B-cell lymphomas, and small-cell lung cancer. The